vs

Side-by-side financial comparison of Douglas Elliman Inc. (DOUG) and SunCoke Energy, Inc. (SXC). Click either name above to swap in a different company.

SunCoke Energy, Inc. is the larger business by last-quarter revenue ($480.2M vs $245.4M, roughly 2.0× Douglas Elliman Inc.). Douglas Elliman Inc. runs the higher net margin — 27.9% vs -17.8%, a 45.8% gap on every dollar of revenue. On growth, Douglas Elliman Inc. posted the faster year-over-year revenue change (0.9% vs -1.2%). SunCoke Energy, Inc. produced more free cash flow last quarter ($32.8M vs $-14.7M). Over the past eight quarters, Douglas Elliman Inc.'s revenue compounded faster (10.7% CAGR vs -0.8%).

Douglas Elliman Inc. is a leading U.S.-based residential real estate brokerage firm. It offers luxury property sales, rentals, property management, and advisory solutions, serving high-net-worth clients across key metro markets including New York, California, Florida, and Texas.

Energy Brands, also doing business as Glacéau, is a privately owned subsidiary of the Coca-Cola Company based in Whitestone, Queens, New York, that manufactures and distributes various lines of drinks marketed as enhanced water. Founded in May 1996 by J. Darius Bikoff with an electrolyte enhanced line of water called Smartwater, Energy Brands initially distributed its products to health food stores and independent retailers in the New York area. Adding Fruitwater and Vitaminwater to its line ...

DOUG vs SXC — Head-to-Head

Bigger by revenue
SXC
SXC
2.0× larger
SXC
$480.2M
$245.4M
DOUG
Growing faster (revenue YoY)
DOUG
DOUG
+2.1% gap
DOUG
0.9%
-1.2%
SXC
Higher net margin
DOUG
DOUG
45.8% more per $
DOUG
27.9%
-17.8%
SXC
More free cash flow
SXC
SXC
$47.5M more FCF
SXC
$32.8M
$-14.7M
DOUG
Faster 2-yr revenue CAGR
DOUG
DOUG
Annualised
DOUG
10.7%
-0.8%
SXC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOUG
DOUG
SXC
SXC
Revenue
$245.4M
$480.2M
Net Profit
$68.6M
$-85.6M
Gross Margin
Operating Margin
27.3%
-20.4%
Net Margin
27.9%
-17.8%
Revenue YoY
0.9%
-1.2%
Net Profit YoY
1243.4%
-461.2%
EPS (diluted)
$0.80
$-1.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOUG
DOUG
SXC
SXC
Q4 25
$245.4M
$480.2M
Q3 25
$262.8M
$487.0M
Q2 25
$271.4M
$434.1M
Q1 25
$253.4M
$436.0M
Q4 24
$243.3M
$486.0M
Q3 24
$266.3M
$490.1M
Q2 24
$285.8M
$470.9M
Q1 24
$200.2M
$488.4M
Net Profit
DOUG
DOUG
SXC
SXC
Q4 25
$68.6M
$-85.6M
Q3 25
$-24.7M
$22.2M
Q2 25
$-22.7M
$1.9M
Q1 25
$-6.0M
$17.3M
Q4 24
$-6.0M
$23.7M
Q3 24
$-27.2M
$30.7M
Q2 24
$-1.7M
$21.5M
Q1 24
$-41.5M
$20.0M
Operating Margin
DOUG
DOUG
SXC
SXC
Q4 25
27.3%
-20.4%
Q3 25
-4.1%
2.8%
Q2 25
-2.0%
2.3%
Q1 25
-2.1%
6.9%
Q4 24
-6.7%
7.3%
Q3 24
-2.8%
9.6%
Q2 24
-1.3%
7.4%
Q1 24
-20.7%
7.1%
Net Margin
DOUG
DOUG
SXC
SXC
Q4 25
27.9%
-17.8%
Q3 25
-9.4%
4.6%
Q2 25
-8.4%
0.4%
Q1 25
-2.4%
4.0%
Q4 24
-2.5%
4.9%
Q3 24
-10.2%
6.3%
Q2 24
-0.6%
4.6%
Q1 24
-20.7%
4.1%
EPS (diluted)
DOUG
DOUG
SXC
SXC
Q4 25
$0.80
$-1.00
Q3 25
$-0.29
$0.26
Q2 25
$-0.27
$0.02
Q1 25
$-0.07
$0.20
Q4 24
$-0.06
$0.28
Q3 24
$-0.33
$0.36
Q2 24
$-0.02
$0.25
Q1 24
$-0.50
$0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOUG
DOUG
SXC
SXC
Cash + ST InvestmentsLiquidity on hand
$115.5M
$88.7M
Total DebtLower is stronger
$685.5M
Stockholders' EquityBook value
$183.9M
$597.3M
Total Assets
$444.4M
$1.8B
Debt / EquityLower = less leverage
1.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOUG
DOUG
SXC
SXC
Q4 25
$115.5M
$88.7M
Q3 25
$143.0M
$80.4M
Q2 25
$136.3M
$186.2M
Q1 25
$136.8M
$193.7M
Q4 24
$145.5M
$189.6M
Q3 24
$151.4M
$164.7M
Q2 24
$92.9M
$81.9M
Q1 24
$91.5M
$120.1M
Total Debt
DOUG
DOUG
SXC
SXC
Q4 25
$685.5M
Q3 25
$691.1M
Q2 25
$493.4M
Q1 25
$492.9M
Q4 24
$492.3M
Q3 24
$491.8M
Q2 24
$491.3M
Q1 24
$490.8M
Stockholders' Equity
DOUG
DOUG
SXC
SXC
Q4 25
$183.9M
$597.3M
Q3 25
$115.1M
$695.9M
Q2 25
$137.6M
$677.7M
Q1 25
$158.2M
$684.6M
Q4 24
$162.2M
$680.2M
Q3 24
$173.6M
$658.6M
Q2 24
$196.9M
$636.9M
Q1 24
$195.1M
$623.0M
Total Assets
DOUG
DOUG
SXC
SXC
Q4 25
$444.4M
$1.8B
Q3 25
$480.6M
$1.9B
Q2 25
$489.0M
$1.6B
Q1 25
$493.9M
$1.7B
Q4 24
$493.9M
$1.7B
Q3 24
$502.7M
$1.7B
Q2 24
$463.9M
$1.7B
Q1 24
$461.1M
$1.7B
Debt / Equity
DOUG
DOUG
SXC
SXC
Q4 25
1.15×
Q3 25
0.99×
Q2 25
0.73×
Q1 25
0.72×
Q4 24
0.72×
Q3 24
0.75×
Q2 24
0.77×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOUG
DOUG
SXC
SXC
Operating Cash FlowLast quarter
$-14.4M
$56.6M
Free Cash FlowOCF − Capex
$-14.7M
$32.8M
FCF MarginFCF / Revenue
-6.0%
6.8%
Capex IntensityCapex / Revenue
0.1%
5.0%
Cash ConversionOCF / Net Profit
-0.21×
TTM Free Cash FlowTrailing 4 quarters
$-17.2M
$42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOUG
DOUG
SXC
SXC
Q4 25
$-14.4M
$56.6M
Q3 25
$5.5M
$9.2M
Q2 25
$642.0K
$17.5M
Q1 25
$-5.6M
$25.8M
Q4 24
$-9.0M
$60.9M
Q3 24
$9.0M
$107.2M
Q2 24
$1.3M
$-9.3M
Q1 24
$-27.3M
$10.0M
Free Cash Flow
DOUG
DOUG
SXC
SXC
Q4 25
$-14.7M
$32.8M
Q3 25
$4.7M
$-16.3M
Q2 25
$-575.0K
$4.9M
Q1 25
$-6.7M
$20.9M
Q4 24
$-10.2M
$36.1M
Q3 24
$7.7M
$92.1M
Q2 24
$432.0K
$-26.8M
Q1 24
$-29.4M
$-5.5M
FCF Margin
DOUG
DOUG
SXC
SXC
Q4 25
-6.0%
6.8%
Q3 25
1.8%
-3.3%
Q2 25
-0.2%
1.1%
Q1 25
-2.6%
4.8%
Q4 24
-4.2%
7.4%
Q3 24
2.9%
18.8%
Q2 24
0.2%
-5.7%
Q1 24
-14.7%
-1.1%
Capex Intensity
DOUG
DOUG
SXC
SXC
Q4 25
0.1%
5.0%
Q3 25
0.3%
5.2%
Q2 25
0.4%
2.9%
Q1 25
0.4%
1.1%
Q4 24
0.5%
5.1%
Q3 24
0.5%
3.1%
Q2 24
0.3%
3.7%
Q1 24
1.0%
3.2%
Cash Conversion
DOUG
DOUG
SXC
SXC
Q4 25
-0.21×
Q3 25
0.41×
Q2 25
9.21×
Q1 25
1.49×
Q4 24
2.57×
Q3 24
3.49×
Q2 24
-0.43×
Q1 24
0.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOUG
DOUG

Commissions And Other Brokerage Income$240.3M98%
Property Management Income$2.8M1%
Property Management$2.2M1%

SXC
SXC

Segment breakdown not available.

Related Comparisons